Castleview Partners’s Steris STE Stock Holding History

Castleview Partners’s Portfolio STE Stock Details STE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-12,413	Closed	-$51	–	990
2021 Q4	$51	Buy	+12,413	New	+$2.84M	﹤0.01%	882

Other funds holding STE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Castleview Partners's STE Position: Q1 2022 in Review

Castleview Partners sold out of Steris (STE) in Q1 2022, closing a stake of 12,413 shares — an estimated $51 sold.

Castleview Partners first reported a position in STE in Q4 2021 and held it in 1 quarter. The position peaked at $51 in Q4 2021. 645 funds tracked by Wall St. Rank hold STE as of Q1 2022.

Castleview Partners reported no remaining Steris position as of Q1 2022 after selling out during the quarter.
Castleview Partners sold 12,413 Steris shares in Q1 2022, an estimated $51.
Castleview Partners first reported a position in Steris in Q4 2021 and held it in 1 quarter.
Castleview Partners's Steris position peaked at $51 in Q4 2021.
645 funds tracked by Wall St. Rank held Steris as of Q1 2022.

Based on Castleview Partners's 13F filing for Q1 2022, filed 16 May 2022.